Equities
Health CareMedical Equipment and Services
  • Price (AUD)32.54
  • Today's Change0.52 / 1.62%
  • Shares traded306.98k
  • 1 Year change+43.16%
  • Beta0.7760
Data delayed at least 20 minutes, as of Nov 08 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Ansell Ltd's net income fell -48.42% from 148.30m to 76.50m despite relatively flat revenues. A contributing factor has been an increase in the selling, general and administrative costs as a percentage of sales from 24.71% to 26.51%.
Gross margin38.58%
Net profit margin4.79%
Operating margin7.98%
Return on assets2.68%
Return on equity4.38%
Return on investment3.16%
More ▼

Cash flow in USDView more

In 2024, Ansell Ltd increased its cash reserves by 472.33%, or 752.90m. Cash Flow from Financing totalled 540.80m or 33.40% of revenues. In addition the company generated 272.30m in cash from operations while cash used for investing totalled 63.40m.
Cash flow per share1.74
Price/Cash flow per share21.13
Book value per share19.53
Tangible book value per share8.66
More ▼

Balance sheet in USDView more

Ansell Ltd has a Debt to Total Capital ratio of 30.98%, a higher figure than the previous year's 23.55%.
Current ratio3.84
Quick ratio2.75
Total debt/total equity0.4524
Total debt/total capital0.3098
More ▼

Growth rates in USD

Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -17.23% and -49.33%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.44%
Div growth rate (5 year)-4.12%
Payout ratio (TTM)26.80%
EPS growth(5 years)-6.16
EPS (TTM) vs
TTM 1 year ago
-49.97
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.